Palantir shares rise 5% premarket as AI-fueled demand powers annual guidance raise
On Friday, Benchmark analysts reiterated their Buy rating and $10.00 price target for Odysight.AI Inc. (NASDAQ: ODYS), following the company’s first-quarter performance for the year 2025. The firm highlighted Odysight.AI’s revenue, which surpassed expectations, and the company’s strategic shift towards Aerospace and Defense (A&D) and Industrial Technology.
Odysight.AI reported a flat sequential backlog, despite including the remainder of its legacy healthcare asset in the first-quarter results. The company’s move to a pure play in A&D and Industrial Technology sectors is part of its aggressive push into these markets. The transition was marked by the recognition of the remaining healthcare asset, aimed at streamlining the company’s focus.
At the end of the quarter, Odysight.AI boasted a substantial cash position of approximately $37 million, bolstered by a recent capital raise. This financial strength positions the company to pursue Predictive Maintenance (Pdm) and Condition-Based Monitoring (CBM) opportunities on a global scale.
Additionally, Odysight.AI announced a new purchase order from a European industrial customer. This order is for monitoring systems for cables and belts used in cranes, elevators, and machinery, reflecting the company’s expansion into new applications of its technology. The versatility of Odysight.AI’s software is seen as an advantage, as it can be applied to various A&D and Industrial Technology derivatives, such as cable and belt tension monitoring.
Benchmark’s analysis suggests that deals like the recent purchase order are expected to accelerate throughout the year, as Odysight.AI leverages its multi-disciplined algorithms across different sectors. The firm’s reiteration of the Buy rating is based on the company’s potential to capitalize on its technological capabilities and substantial cash reserves.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.